Search the Blog
Submit
Displaying 61 - 70 of 575 blog posts

BC Ride propels prostate cancer research

The support of the BC Cancer Foundation and, by extension its generous donors, have been instrumental in our research successes to date. An example is our work on liquid biopsies for men with advanced prostate cancer. For these men, understanding the genetic profile of their cancer is important to try and develop personalized or precision medicine strategies, where we tailor treatment to a particular patient and the individual make-up of their cancer. This is usually done with a biopsy, but for men with advanced prostate cancer where the cancer typically metastasizes to the bone, this is...

Cutting-edge research driven by patient experience

Holding leadership roles at the BC Cancer Agency means that much of my time is spent in meetings and teleconference calls. This may sound boring, but meeting with other physicians and health care practitioners is essential to delivering state-of-the-art, quality oncology care with a patient-centred approach, which is very important to all of us the BC Cancer Agency. But what does ‘a patient-centred’ approach actually mean? For me, it's making sure that our patients can access proven effective treatments as well as the most promising clinical trials; that the systems are in place to make sure...

Prostate cancer clinical trials yield promise

Hello, I’m Dr. Kim Nguyen Chi, medical oncologist at the BC Cancer Agency – Vancouver Centre where I’m also the Regional Medical Director. My specialty area is prostate cancer for both my clinical work and research activities. My research is focused on clinical trials and development of biomarkers. Clinical trials are research involving people with cancer where we are trying to develop new treatments, or new ways of using old treatment, to help people with cancer do better. Biomarkers are needed in cancer to help us determine a person’s prognosis and/or response to therapy so we can better...

Introducing August guest blogger Dr. Kim Chi

Special thanks to Dr. Daniel Renouf for sharing the incredible progress being made to treat pancreatic cancer. It is a true testament to the importance of events such as the Glotman-Simpson Cypress Challenge , proceeds from which fund this life-saving work. We are pleased to welcome back to our blog Dr. Kim Chi, medical oncologist and director of clinical research at BC Cancer, for the month of August. Dr. Chi will blog about his work advancing treatment for prostate cancer through a number of promising clinical trials. Dr. Chi will also share his experience participating in this year’s...

Philanthropy fuels progress for pancreatic cancer research

In my previous blog I discussed some of the exciting research happening in pancreatic cancer led by our group at the BC Cancer Agency and Pancreas Centre BC. It’s safe to say that none of this would be possible without the very generous donors of the BC Cancer Foundation. When I came to the BC Cancer Agency several years ago, a major fundraising initiative by the Foundation helped create the Pancreas Centre BC. Donor support helped generate an explosion of pancreatic cancer research in BC, making us now a national leader in this area. The 10 th annual Glotman-Simpson Cypress Challenge , which...

Combining immunotherapy and chemotherapy to treat pancreatic cancer

Thanks to everyone who had a chance to look at last week’s blog. This week I will share with you a little bit more about my everyday work, and discuss an exciting new clinical trial now underway for pancreatic cancer. One of the fulfilling aspects of working as a clinician-researcher is that every day is different. Several days of the week I spend in the oncology clinic at BC Cancer. We have a great clinical team, including a nurse practitioner, family doctor specializing in oncology, and multiple medical trainees including medical students, residents, and medical oncology fellows. In...

Introducing July guest blogger Dr. Daniel Renouf

Thank you to Dr. Ma for updating us on the status of VERO at BC Cancer. It is exciting to read about the first patient procedure that took place and to know that our generous donors are fuelling this progress. We are pleased to welcome back to our blog Dr. Daniel Renouf, medical oncologist and co-director of Pancreas Centre BC, for the month of July. Dr. Renouf will discuss the life-saving research advancements underway for pancreatic cancer, the deadliest cancer facing Canadians today. He will also highlight the impact of the 10th annual Cypress Challenge, which takes place Aug. 13. Thanks...

First patient treated with VERO

It is very exciting for me to share with you that the first patient was treated using VERO last week. It was a true testament of the power of philanthropy to improve patient outcomes. The first patient treated with VERO is a patient with cancer of the bile duct. We opted to treat them using VERO because of the pivoting ring feature of the machine, which allowed us to maneuver the radiation beams to target the tumour, while sparing most of the heart from significant irradiation. This is a basic function of VERO, yet in that there is already an advantage over the most sophisticated treatments...

Tapping into VERO's full potential

One of the most exciting aspects about VERO is how it will improve patient treatments well into the future. Indeed, part of the reason why we selected technology like VERO at BC Cancer was that we saw its future developmental potential. We are just at the beginning stages of using VERO’s full potential. As time goes on, we will be rolling out increasingly sophisticated treatment techniques and that is what makes it so exciting to work with. Every patient who undergoes treatment on the VERO is part of our ethics-approved research protocol where we analyze the many ways in which the technology...

Pages